These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 26631030
1. Genetic variants in IL12 influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma development in a Chinese male population. Tan A, Gao Y, Yao Z, Su S, Jiang Y, Xie Y, Xian X, Mo Z. Tumour Biol; 2016 May; 37(5):6343-8. PubMed ID: 26631030 [Abstract] [Full Text] [Related]
4. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM. Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522 [Abstract] [Full Text] [Related]
5. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, Zhang H, Cao G. Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206 [Abstract] [Full Text] [Related]
7. Genetic variants in class II transactivator are associated with chronic hepatitis B virus infection in the Han Chinese population. Su M, Chen Z, Zheng J, Chen Y. Int J Immunogenet; 2020 Oct; 47(5):435-442. PubMed ID: 32103629 [Abstract] [Full Text] [Related]
9. Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population. Yao JY, Chao K, Li MR, Wu YQ, Zhong BH. World J Gastroenterol; 2015 Apr 14; 21(14):4232-9. PubMed ID: 25892873 [Abstract] [Full Text] [Related]
11. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians. Wang P, Wu C, Li Y, Gong Y, Shen N. Gene; 2020 Jun 05; 742():144585. PubMed ID: 32173542 [Abstract] [Full Text] [Related]
12. UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma. Liu Y, Song C, Ni H, Jiao W, Gan W, Dong X, Liu J, Zhu L, Zhai X, Hu Z, Li J. J Viral Hepat; 2018 Nov 05; 25(11):1363-1371. PubMed ID: 29969176 [Abstract] [Full Text] [Related]
13. CDC25B is associated with the risk of hepatocellular carcinoma, but not related to persistent infection of hepatitis B virus in a Chinese population. Wang P, Peng J, Gong Y, Shen N. Mol Biol Rep; 2020 May 05; 47(5):3361-3368. PubMed ID: 32248384 [Abstract] [Full Text] [Related]
16. Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in Guangxi population: a case-control study. Liu Y, Xie L, Zhao J, Huang X, Song L, Luo J, Ma L, Li S, Qin X. Medicine (Baltimore); 2015 Apr 05; 94(13):e702. PubMed ID: 25837767 [Abstract] [Full Text] [Related]
17. Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma. Wang WT, Li Z, Shi M, Zhu H, Xiong X, Shang J, Liu J, Teng M, Yang M. Oncotarget; 2016 Aug 30; 7(35):56501-56507. PubMed ID: 27489354 [Abstract] [Full Text] [Related]